Vaginitis

New England Journal of Medicine

Volumn 337, Issue 26, 1997, Pages 1896-1903

  Sobel, Jack D ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Henry Ford Health System Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORIC ACID; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; METRONIDAZOLE; PAROMOMYCIN; TINIDAZOLE;

CANDIDA ALBICANS; CLINICAL FEATURE; DYSPAREUNIA; FEMALE; FUNGUS IDENTIFICATION; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; NEUTROPENIA; PRIORITY JOURNAL; RASH; REVIEW; TRICHOMONIASIS; VAGINA CANDIDIASIS; VAGINA DISCHARGE; VAGINITIS; VULVA PRURITUS;

CANDIDIASIS, VULVOVAGINAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIV SEROPOSITIVITY; HUMANS; RECURRENCE; TRICHOMONAS VAGINITIS; VAGINITIS; VAGINOSIS, BACTERIAL; VULVOVAGINITIS;

EID: 0031454303     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199712253372607     Document Type: Review

References (56)

1. Berg AO, Heidrich FE, Fihn SD, et al. Establishing the cause of genitourinary symptoms in women in a family practice: comparison of clinical examination and comprehensive microbiology. JAMA 1984;251:620-5.
2. Geiger AM, Foxman B, Gillespie BW. The epidemiology of vulvovaginal candidiasis among university students. Am J Public Health 1995;85:1146-8.
3. Geiger AM, Foxman B. Risk factors in vulvovaginal candidiasis: a case-control study among university students. Epidemiology 1996;7:182-7.
4. Hurley R, De Louvois J. Candida vaginitis. Postgrad Med J 1979;55: 645-7.
5. Candidosis of the genitalia. In: Odds FC. Candida and candidosis: a review and bibliography. 2nd ed. London: Baillière Tindall, 1988:124-35.
6. Horowitz BJ, Giaquinta D, Ito S. Evolving pathogens in vulvovaginal candidiasis: implications for patient care. J Clin Pharmacol 1992;32:248-55.
7. Foxman B. The epidemiology of vulvovaginal candidiasis: risk factors. Am J Public Health 1990;80:329-31.
8. Amsel R, Totten PA, Spiegel CA, Chen KS, Eschenbach DA, Holmes KK. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22.
9. Ferris DG, Dekle C, Litaker MS. Women's use of over-the-counter antifungal medications for gynecologic symptoms. J Fam Pract 1996;42:595-600.
10. Reef SE, Levine WC, McNeil MM, et al. Treatment options for vulvovaginal candidiasis, 1993. Clin Infect Dis 1995;20:Suppl 1:S80-S90.
11. Sobel JD, Brooker D, Stein GE, et al. Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Am J Obstet Gynecol 1995;172:1263-8.
12. Houang ET, Chappatte O, Byrne D, Macrae PV, Thorpe JE. Fluconazole levels in plasma and vaginal secretions of patients after a 150-milligram single oral dose and rate of eradication of infection in vaginal candidiasis. Antimicrob Agents Chemother 1990;34:909-10.
13. Sobel JD, Chaim W. Treatment of Torulopsis glabrata vaginitis: a retrospective review of boric acid therapy. Clin Infect Dis 1997;24:649-52.
14. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1985;152:924-35.
15. Vazquez JA, Sobel JD, Demitriou R, Vaishampayan J, Lynch M, Zervos MJ. Karyotyping of Candida albicans isolates obtained longitudinally in women with recurrent vulvovaginal candidiasis. J Infect Dis 1994;170: 1566-9.
16. Spinillo A, Carratta L, Pizzoli G, et al. Recurrent vaginal candidiasis: results of a cohort study of sexual transmission and intestinal reservoir. J Reprod Med 1992;37:343-7.
17. Fidel PJ Jr, Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev 1996;9:335-48.
18. Hilton E, Chandrasekaran V, Rindos P, Isenberg HD. Association of recurrent candidal vaginitis with inheritance of Lewis blood group antigens. J Infect Dis 1995;172:1616-9.
19. Sobel JD, Chaim W. Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis. J Clin Microbiol 1996;34:2497-9.
20. Sobel JD, Vazquez JA. Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with human immunodeficiency virus. Clin Infect Dis 1996;22:726-7.
21. Lossick JC. Epidemiology of urogenital trichomoniasis. In: Honigberg BM, ed. Trichomonads parasitic in humans. New York: Springer-Verlag, 1990:311-23.
22. Laga M, Manoka AT, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: result from a cohort study. AIDS 1993;7:95-102.
23. Soper DE, Bump RC, Hurt WG. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol 1990;163:1016-21.
24. Hammill HA. Trichomonas vaginalis. Obstet Gynecol Clin North Am 1989;16:531-40.
25. Wolner-Hanssen P, Krieger JN, Stevens CE, et al. Clinical manifestations of vaginal trichomoniasis. JAMA 1989;261:571-6.
26. Krieger JN, Tam MR, Stevens CE, et al. Diagnosis of trichomoniasis: comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA 1988;259:1223-7.
27. DeMeo LR, Draper DL, McGregor JA, et al. Evaluation of a deoxyribonucleic acid probe for the detection of Trichomonas vaginalis in vaginal secretions. Am J Obstet Gynecol 1996;174:1339-42.
28. Nyirjesy P, Weitz MV, Gelone SP, Fekete T. Paromomycin for nitroimidazole-resistant trichomoniasis. Lancet 1995;346:1110.
29. Kurohara ML, Kwong FK, Lebherz TB, Klaustermeyer WB. Metronidazole hypersensitivity and oral desensitization. J Allergy Clin Immunol 1991;88:279-80.
30. Hillier S, Holmes KK. Bacterial vaginosis. In: Holmes KK, Mårdh P-A, Sparling PF, Wiesner PJ, eds. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990:547-59.
31. Eschenbach DA, Davick PR, Williams BL, et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989;27:251-6.
32. Hill GB. The microbiology of bacterial vaginosis. Am J Obstet Gynecol 1993;169:450-4.
33. Gardner HL, Dukes CD. Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified "nonspecific" vaginitis. Am J Obstet Gynecol 1955;69:962-76.
34. Eschenbach DA, Hillier SL, Critchlow C, Stevens C, DeRouen T, Holmes KK. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol 1988;158:819-28.
35. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991;29:297-301.
36. Sheiness D, Dix K, Watanabe S, Hillier SL. High levels of Gardnerella vaginalis detected with an oligonucleotide probe combined with elevated pH as a diagnostic indicator of bacterial vaginosis. J Clin Microbiol 1992; 30:642-8.
37. Oleen-Burkey MA, Hillier SL. Pregnancy complications associated with bacterial vaginosis and their estimated costs. Infect Dis Obstet Gynecol 1995;3:149-57.
38. Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med 1988;319:972-8.
39. Eschenbach DA. Bacterial vaginosis: emphasis on upper genital tract complications. Obstet Gynecol Clin North Am 1989;16:593-610.
40. Kurki T, Sivonen A, Renkonen OV, Savia E, Ylikorkala O. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 1992;80:173-7.
41. Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994;308:295-8.
42. McGregor JA, French JI, Parker R, et al. Prevention of premature birth by screening and treatment of common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol 1995;173:157-67.
43. Morales WJ, Schorr S, Albritton J. Effect of metromdazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol 1994;171:345-7.
44. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Cooper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732-6.
45. MacDermott RIJ. Bacterial vaginosis. Br J Obstet Gynaecol 1995;102: 92-4.
46. Platz-Christensen JJ, Sundstrom E, Larsson PG. Bacterial vaginosis and cervical intraepithelial neoplasia. Acta Obstet Gynecol Scand 1994;73: 586-8.
47. Peters N, Van Leeuwen AM, Pieters WJLM, Hollema H, Quint WGV, Burger MPM. Bacterial vaginosis is not important in the etiology of cervical neoplasia: a survey of women with dyskaryotic smears. Sex Transm Dis 1995;22:296-302.
48. Joesoef MR, Schmid GP. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis 1995; 20:Suppl 1:S72-S79.
49. Ferris DG, Litaker MS, Woodward L, Mathis D, Hendrich J. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J Fam Pract 1995;41:443-9.
50. Ahmed-Jushuf IH, Shahmanesh M, Arya OP. The treatment of bacterial vaginosis with a 3 day course of 2% clindamycin cream: results of a multicenter, double blind, placebo controlled trial. Genitourin Med 1995;71: 254-6.
51. Fleury FJ. Adult vaginitis. Clin Obstet Gynecol 1981;24:407-38.
52. Sobel JD. Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2% clindamycin therapy. Am J Obstet Gynecol 1994;171:1215-20.
53. Rhoads JL, Wright DC, Redfield RR, Burke DS. Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA 1987;257:3105-7.
54. Carpenter CC, Mayer KH, Fisher A, Desai MB, Durand L. Natural history of acquired immunodeficiency syndrome in women in Rhode Island. Am J Med 1989;86:771-5.
55. Sobel JD, Schuman P, Mayer K, et al. Candida colonization and mucosal candidiasis in women with or at risk for HIV infection. In: Program and abstracts of the 11th International Conference on AIDS, Vancouver, B.C., July 7-12, 1996:128. abstract.
56. Schuman P, Christensen C, Sobel JD. Aphthous vaginal ulceration in two women with acquired immunodeficiency syndrome. Am J Obstet Gynecol 1996;174:1660-3.